Latest news
Neurological involvement affected one-third of children with TMA in PICUs - Vera HealthVera Health · Wed, 05 Aug 2026 19:54:55 GMTCase Study: Thrombotic Microangiopathy in Systemic Lupus Erythematosus - Cleveland ClinicCleveland Clinic · Thu, 30 Jul 2026 17:33:32 GMTEculizumab Biosimilar Shows Durable Benefit in Long-Term aHUS - Center for BiosimilarsCenter for Biosimilars · Wed, 29 Jul 2026 19:11:46 GMTUltomiris fails to beat placebo in adult HSCT-TMA trial, narrowing approval path to children - AllSciAllSci · Mon, 27 Jul 2026 11:28:04 GMTUpdate on Phase III trial of Ultomiris in adults and adolescents with thrombotic microangiopathy after haematopoietic stem cell transplant - AstraZenecaAstraZeneca · Mon, 27 Jul 2026 07:00:00 GMTPhase 3 Ravulizumab Trial Misses Primary End Point in Transplant-Associated Thrombotic Microangiopathy - Pharmacy TimesPharmacy Times · Mon, 27 Jul 2026 07:00:00 GMTUltomiris miss in rare thrombotic disorder provides another blot on AstraZeneca's copybook - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 07:00:00 GMT